GC Pharma Lights Up to Celebrate ‘World Hemophilia Day’
- S&P 500, Dow end at record highs as weak jobs data eases rate worries
- U.S. Added Only 266,000 Jobs in April, Well Below Estimates
- Roku (ROKU) Surges After Crushing Profit Estimates to Prompt an Upgrade to 'Buy' at Loop Capital
- Dollar broadly weaker after U.S. jobs data disappoint
- Square (SQ) Tops Q1 EPS by 25c
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
The Company features this year’s slogan image on media façade
YONGIN, South Korea--(BUSINESS WIRE)-- GC Pharma (formerly known as Green Cross Corporation), a South Korean biopharmaceutical company, participates in a campaign to celebrate World Hemophilia Day.
As part of GC Pharma’s continued support of the hemophilia community, the company features this year's slogan image on a giant exterior media façade of its main campus in Yongin, South Korea.
Started in 1989 by the World Federation of Hemophilia (WFH), in honor of their founder Frank Schnabel’s birthday, World Hemophilia Day is celebrated each year on April 17th and intended to raise awareness of the disease and other bleeding disorders.
This year’s slogan is “Adapting to Change, sustaining care in a new world”. With this slogan, the global bleeding disorders community emphasizes the continuity of treatment for bleeding disorders, including haemophilia, in a world that has turned into Covid-19.
Hemophilia is a congenital disorder that causes longer-than-normal bleeding due to absent or deficient clotting factor in the blood. Hemophilia A is more common than hemophilia B; hemophilia A affects about 150,000 people, whereas hemophilia B affects about 30,000 people worldwide. Treatment regimens typically include on-demand and/or regular prophylactic infusions of factor replacement therapy to control or prevent the risk of bleeding. People with hemophilia, working closely with their healthcare professionals, can live healthy lives with proper care and adequate treatment.
About GC Pharma
GC Pharma (formerly known as Green Cross Corporation) is a biopharmaceutical company that delivers life-saving and life-sustaining protein therapeutics and vaccines. Headquartered in South Korea, GC Pharma is the largest plasma protein product manufacturer in Asia and has been dedicated to quality healthcare solutions for more than half a century. Green Cross Corporation updated its corporate brand to GC Pharma in early 2018. Green Cross Corporation remains the company's registered, legal name.
Source: GC Pharma
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AHF Issues $100M Homeless Challenge to Mayor Garcetti, L.A. City Council in New L.A. Times Ad
- Ingersoll Rand to Virtually Participate at 2021 Goldman Sachs Industrials & Materials Conference
- LGI Homes Acquires Real Estate Assets of Minnesota Homebuilder
Create E-mail Alert Related CategoriesBusiness Wire, Press Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!